Reprinted with permission of American Journal of Pathology, Bethesda, MD.

As published in American Journal of Pathology Vol. 150, No. 6, pp. 2153-2165, 1997

Disseminated Peritoneal Leiomyomatosis

Clonality Analysis by X Chromosome Inactivation and Cytogenetics of a Clinically Benign Smooth Muscle Proliferation

Bradley J. Quade*, Catherine M. McLachlin+, Malena Soto-Wright#, James Zuckerman#, George L. Mutter*, and Cynthia C. Morton *#
From the Departments of Pathology* and Obstetrics, Gynecology, and Reproductive Biology, # Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and the Department of Pathology, + Victoria Hospital and University of Western Ontario, London, Ontario, Canada

Disseminated peritoneal leiomyomatosis (DPL, leiomyomatosis peritonealis disseminata) is a rare condition in which multiple histologically benign smooth muscle tumorlets diffusely stud peritoneal and omental surfaces in females, predominantly of reproductive age. Although the distribution of these lesions suggests a metastatic process, DPL generally has a benign clinical course and has been regarded as a metaplastic process. We assessed clonality of 42 tumorlets and 15 normal tissues from four females with DPL by analyzing X chromosome inactivation as indicated by the methylation status of the androgen receptor gene (HUMARA). In each of the four patients, the same parental X chromosome was non randomly inactivated in all tumorlets, consistent with a metastatic unicentric neoplasm, or alternatively, selection for an X-linked allele in clonal multicentric lesions. Anomalous demethylation of the marker for X inactivation (HUMARA) was associated with loss of heterozygosity for markers spanning the X chromosome, or monosomy X, in part of one leiomyomatous lesion. Biallelic demethylation of the HUMARA microsatellite polymorphism was also found in one intramural lyomyoma. Two of six DPL lesions karyotyped had cytogenetic abnormalities involving chromosomes 7, 12, and 18, suggesting a pathogenesis in common with uterine leiomyomas. (Am J Pathol 1997, 150:2153-2166)


Table 1. Clinical Features of Four Patients with DPL


TAH, total abdominal hystorectomy; BSO, bilateral salpingo-oopherectomy; HRT, hormone replacement therapy.
*Previously reported.15




Table 2. Nonrandom X Chromosome Inactivation in DPL


Materials from patient 4's hysterectomy were not available (NA) for our review and analysis.





Figure 1. Gross and microscopic pathological features of DPL. The cut surface of a large leiomyomatous mass that arose in the round ligament of patient 1 was firm, white, bulging, whorled, and focally hemorrhagic (A). Innumerable smaller leiomyomatous lesions ranging from 0.01 to 2.0 cm in greatest dimension studded the peritoneal surfaces of the anterior uterus, broad ligaments, para-ovarian soft tissue (A), posterior uterus (B), and omentum (C and E). These nodular lesions contained interwoven fascicles of smooth muscle cells with mild to moderate hypercellulatity and without coagulative tumor necrosis or cytological or nuclear atypia (D and E). Mitotic figures were rare (<2 per 100 high-powerfields in 300 fields counted; arrow in F). Atypical mitotic figures were not present. For comparison, uterine smooth muscle tumors without significant atypia or necrosis are generally not considered to have an uncertain malignant potential until the mitotic index is greater than 5 mitotic figures per 10 high-powerfields.32,31,84 In all four patients, microscopic foci of endometrial epithelium and stroma were present in association with leiomyomatous proliferations and resembled endometriosis (not shown). In patient 2, a microscopic cyst lined by histologically benign simple endocervical-type epithelium was found in one leiomyomatous nodule (not shown).





Figure 2.Analysis of clonality by PCR amplification of the HUMARA microsatellite polymorpbism with (+) and without (-) previous HhaI restriction digestion. DNA was extracted from paraffin-embedded normal (A), omental (B), and non-omental peritoneal (C) leiomyomatous nodules from patient 1. A: Mildly skewed X chromosome inactivation was found in normal tissues. B and C: Nonrandom X inactivation was found in all leiomyomatous lesions. C: Anomalous patterns of HUMARA PCR were found in one of two samples from the large round ligament mass and in both samples from the intramural uterine leiomyoma.





Figure 3. Evidence of focal loss of heterozygosity (A) and DNA methylation (B) of the X chromosome in leiomyomatous lesions in patient 1. Paraffin-extracted DNA from patient 1 was amplified using primers to the HPRTB locus at Xq26.1 and the KAL locus at Xp22.3. In A, LOH for the markers spanning the entire X chromosome was found in one of two samples (arrow) from the 7.5-cm round ligament mass shown in Figure 1A. LOH for the X chromosome was not found in eight omental and seven other extra-omental leiomyomatous lesions. In B, DNA from samples (one from the round ligament mass and one from the intramural leiomyoma) with anomalous results for PCR amplification at the HUMARA locus were amplified with primers for HPRTB and KAL after previous HhaI digestion. These anomalous samples were compared with HhaI-digested DNA from the other round ligament mass sample (lacking LOH at HUMARA) and one control tissue (Meckel's diverticulum) with a polygonal pattern at the HUMARA locus. The lack of amplification at HUMARA, but not HPRTB and KAL, after HhaI digestion is consistent with an epigenetic loss of DNA methylation at HUMARA in the intramural leiomyoma.




Table 3. Cytogenetic Analysis of DPL Lesions

*The bracketed number after each karyotype indicates the number of analyzed metaphases with that karyotype.





Figure 4. Cytogenetic abnormalities in DPL patient 1 included structural rearrangements of chromosomes 12 (A) and 7 and 18 (B). The karyotype of the large round ligament leiomyoma (Figure 1A) was 46,XX,add(12) (qter)[11]/46,XX[6]. The additional chromatin on cbromosome 12 is indicated by the arrowhead in A. The abnormal karyotype of an omental nodule was 46,XX,t(7;18)(q22;p11.3)[15]/46,XX[5]. The translocation is identified by the arrowheads in panel B. The bracketed number following each karyotype indicates the number of analyzed metaphases with that karyotype.